This Fortnight in Medicine X

Sensible Medicine · Adam Cifu, MD, John Mandrola, and Andrew J Foy

October 8, 202550m 52s

Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

Two papers this week, with a bunch of articles that we referenced in the conversation. Also, the last Fortnight podcast was accidentally posted behind a paywall. It is now up and free to listen to. My apologies.

Sensible Medicine is reader-supported. If you appreciate our work, consider becoming a free or paid subscriber.

Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial

* Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention

* Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children

* Cerebral folate receptor autoantibodies in autism spectrum disorder

* What Is Leucovorin, the Medicine Being Approved for Autism Treatment?

* Clinicaltrial.gov search

Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices

* Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

* Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

* Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction

* Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

← All episodes of Sensible Medicine